Back to Search
WADDAH ARAFAT MD
MD
Medical Oncology Physician
NPI: 1710299482IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
R7163(TX)
Education
OTHER
Class of 2009
Research & Publications (14)
Doomed trials for promising adenoviruses: a rationale for success.
PMID 15020624·J Clin Oncol·2004
8-other
An adenovirus encoding proapoptotic Bax synergistically radiosensitizes malignant glioma.
PMID 12605984·Int J Radiat Oncol Biol Phys·2003
7-preclinical
Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv.
PMID 11896464·Gene Ther·2002
7-preclinical
Adenovirus-mediated transfer of BAX driven by the vascular endothelial growth factor promoter induces apoptosis in lung cancer cells.
PMID 12161185·Mol Ther·2002
8-other
An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites.
PMID 11426962·Gynecol Oncol·2001
8-other
Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications.
PMID 11489832·Clin Cancer Res·2001
7-preclinical
Bax-induced apoptosis as a novel gene therapy approach for carcinoma of the cervix.
PMID 11606099·Gynecol Oncol·2001
8-other
Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model.
PMID 10680015·Gene Ther·2000
7-preclinical
A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial.
PMID 10955787·Clin Cancer Res·2000
3-trial
An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer.
PMID 10933979·Mol Ther·2000
7-preclinical
Antineoplastic effect of anti-erbB-2 intrabody is not correlated with scFv affinity for its target.
PMID 11023197·Cancer Gene Ther·2000
8-other
Genetically modified CD34+ cells exert a cytotoxic bystander effect on human endothelial and cancer cells.
PMID 11106265·Clin Cancer Res·2000
7-preclinical
Gene therapy for carcinoma of the breast: Pro-apoptotic gene therapy.
PMID 11250691·Breast Cancer Res·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 5200 HARRY HINES BLVD
DALLAS, TX 75235 - Phone
- (214) 590-4656
Quick Facts
- NPI
- 1710299482
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 17
- Publications
- 14
Are you this provider?
Claim Your Profile